AEDIFICA (AED.BR) Stock Fundamental Analysis

EBR:AED • BE0003851681

77.55 EUR
-0.25 (-0.32%)
Last: Feb 20, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, AED scores 4 out of 10 in our fundamental rating. AED was compared to 41 industry peers in the Diversified REITs industry. While AED is still in line with the averages on profitability rating, there are concerns on its financial health. AED is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • AED had positive earnings in the past year.
  • AED had a positive operating cash flow in the past year.
  • AED had positive earnings in each of the past 5 years.
  • AED had a positive operating cash flow in each of the past 5 years.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • AED has a Return On Assets of 2.73%. This is comparable to the rest of the industry: AED outperforms 58.54% of its industry peers.
  • AED has a Return On Equity (4.96%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 3.52%, AED is in line with its industry, outperforming 56.10% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AED is in line with the industry average of 3.45%.
  • The last Return On Invested Capital (3.52%) for AED is above the 3 year average (3.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • AED has a Profit Margin of 49.82%. This is in the better half of the industry: AED outperforms 65.85% of its industry peers.
  • In the last couple of years the Profit Margin of AED has declined.
  • Looking at the Operating Margin, with a value of 77.70%, AED is in the better half of the industry, outperforming 70.73% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AED has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 97.93%, AED belongs to the top of the industry, outperforming 97.56% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AED has remained more or less at the same level.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AED is destroying value.
  • The number of shares outstanding for AED remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, AED has more shares outstanding
  • AED has a worse debt/assets ratio than last year.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • AED has an Altman-Z score of 0.93. This is a bad value and indicates that AED is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of AED (0.93) is comparable to the rest of the industry.
  • AED has a debt to FCF ratio of 24.91. This is a negative value and a sign of low solvency as AED would need 24.91 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 24.91, AED is doing worse than 68.29% of the companies in the same industry.
  • A Debt/Equity ratio of 0.58 indicates that AED is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.58, AED is in the better half of the industry, outperforming 65.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.93
ROIC/WACC0.56
WACC6.27%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AED's Current ratio of 0.35 is in line compared to the rest of the industry. AED outperforms 41.46% of its industry peers.
  • A Quick Ratio of 0.35 indicates that AED may have some problems paying its short term obligations.
  • AED's Quick ratio of 0.35 is in line compared to the rest of the industry. AED outperforms 46.34% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 114.94% over the past year.
  • The Earnings Per Share has been decreasing by -7.20% on average over the past years.
  • Looking at the last year, AED shows a quite strong growth in Revenue. The Revenue has grown by 8.06% in the last year.
  • Measured over the past years, AED shows a very strong growth in Revenue. The Revenue has been growing by 23.35% on average per year.
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

  • AED is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.19% yearly.
  • The Revenue is expected to grow by 5.12% on average over the next years.
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 16.19, the valuation of AED can be described as correct.
  • AED's Price/Earnings ratio is in line with the industry average.
  • AED's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.99.
  • The Price/Forward Earnings ratio is 14.75, which indicates a correct valuation of AED.
  • AED's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AED is more expensive than 65.85% of the companies in the same industry.
  • AED is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.19
Fwd PE 14.75
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 63.41% of the companies in the same industry are cheaper than AED, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of AED indicates a rather expensive valuation: AED more expensive than 80.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 35.58
EV/EBITDA 22.43
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • AED has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.88
PEG (5Y)N/A
EPS Next 2Y3.32%
EPS Next 3Y3.19%

3

5. Dividend

5.1 Amount

  • AED has a Yearly Dividend Yield of 3.68%.
  • AED's Dividend Yield is slightly below the industry average, which is at 5.41.
  • Compared to an average S&P500 Dividend Yield of 1.81, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

  • The dividend of AED is nicely growing with an annual growth rate of 22.82%!
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • 105.58% of the earnings are spent on dividend by AED. This is not a sustainable payout ratio.
  • The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (2/20/2026, 7:00:00 PM)

77.55

-0.25 (-0.32%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-13
Earnings (Next)04-27
Inst Owners41.34%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.69B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts82.22
Price Target80.37 (3.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.95%
PT rev (3m)7.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.62%
EPS NY rev (3m)0.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 16.19
Fwd PE 14.75
P/S 10.45
P/FCF 35.58
P/OCF 12.63
P/B 1.04
P/tB 1.07
EV/EBITDA 22.43
EPS(TTM)4.79
EY6.18%
EPS(NY)5.26
Fwd EY6.78%
FCF(TTM)2.18
FCFY2.81%
OCF(TTM)6.14
OCFY7.92%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)3.88
PEG (5Y)N/A
Graham Number89.66
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.93
F-Score7
WACC6.27%
ROIC/WACC0.56
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.51%
EBIT Next 3Y6.39%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 4 / 10 to AED.BR.


What is the valuation status of AEDIFICA (AED.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


How profitable is AEDIFICA (AED.BR) stock?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AED stock?

The Price/Earnings (PE) ratio for AEDIFICA (AED.BR) is 16.19 and the Price/Book (PB) ratio is 1.04.


Can you provide the financial health for AED stock?

The financial health rating of AEDIFICA (AED.BR) is 2 / 10.